This may contribute to the local microthrombus formation in alveolar capillaries that occurs in COVID-19 patients, as fibrin is not degraded by tissue plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) [166,167]. The gene discussed is PLAU; the disease is COVID-19.